Published in Nature on November 18, 1987
The scanning model for translation: an update. J Cell Biol (1989) 31.23
Induction of medulloblastomas in p53-null mutant mice by somatic inactivation of Rb in the external granular layer cells of the cerebellum. Genes Dev (2000) 5.71
Antioncogenes and human cancer. Proc Natl Acad Sci U S A (1993) 4.09
Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumor cells. Proc Natl Acad Sci U S A (1990) 4.06
Molecular cloning of cellular genes encoding retinoblastoma-associated proteins: identification of a gene with properties of the transcription factor E2F. Mol Cell Biol (1992) 3.58
The activation domain of transcription factor PU.1 binds the retinoblastoma (RB) protein and the transcription factor TFIID in vitro: RB shows sequence similarity to TFIID and TFIIB. Proc Natl Acad Sci U S A (1993) 2.90
Retinoblastoma cancer suppressor gene product is a substrate of the cell cycle regulator cdc2 kinase. EMBO J (1991) 2.84
An activity specified by the osteosarcoma line U2OS can substitute functionally for ICP0, a major regulatory protein of herpes simplex virus type 1. J Virol (1995) 2.82
Transcriptional repression of the E2-containing promoters EIIaE, c-myc, and RB1 by the product of the RB1 gene. Mol Cell Biol (1992) 2.78
The accumulation of an E2F-p130 transcriptional repressor distinguishes a G0 cell state from a G1 cell state. Mol Cell Biol (1996) 2.47
A single amino acid substitution results in a retinoblastoma protein defective in phosphorylation and oncoprotein binding. Proc Natl Acad Sci U S A (1990) 2.46
Definition of the minimal simian virus 40 large T antigen- and adenovirus E1A-binding domain in the retinoblastoma gene product. Mol Cell Biol (1990) 2.27
Two distinct and frequently mutated regions of retinoblastoma protein are required for binding to SV40 T antigen. EMBO J (1990) 2.26
Structure and expression of the murine retinoblastoma gene and characterization of its encoded protein. Proc Natl Acad Sci U S A (1989) 2.25
Loss of heterozygosity for the short arm of chromosome 1 in human neuroblastomas: correlation with N-myc amplification. Proc Natl Acad Sci U S A (1989) 2.25
The t(11;14)(p15;q11) in a T-cell acute lymphoblastic leukemia cell line activates multiple transcripts, including Ttg-1, a gene encoding a potential zinc finger protein. Mol Cell Biol (1989) 2.24
The subcellular localization of E2F-4 is cell-cycle dependent. Proc Natl Acad Sci U S A (1997) 2.24
Human retinoblastoma susceptibility gene: genomic organization and analysis of heterozygous intragenic deletion mutants. Proc Natl Acad Sci U S A (1988) 2.22
Cytoplasmic localization of human cdc25C during interphase requires an intact 14-3-3 binding site. Mol Cell Biol (1999) 2.21
The E7 proteins of the nononcogenic human papillomavirus type 6b (HPV-6b) and of the oncogenic HPV-16 differ in retinoblastoma protein binding and other properties. J Virol (1990) 2.19
Prohibitin, an evolutionarily conserved intracellular protein that blocks DNA synthesis in normal fibroblasts and HeLa cells. Mol Cell Biol (1991) 2.04
Mutations in the RB1 gene and their effects on transcription. Mol Cell Biol (1989) 2.00
T antigens of simian virus 40: molecular chaperones for viral replication and tumorigenesis. Microbiol Mol Biol Rev (2002) 1.92
C-terminal truncation of the retinoblastoma gene product leads to functional inactivation. Proc Natl Acad Sci U S A (1990) 1.91
Promoter deletion and loss of retinoblastoma gene expression in human prostate carcinoma. Proc Natl Acad Sci U S A (1990) 1.82
The genomic landscape of retinoblastoma: a review. Clin Experiment Ophthalmol (2013) 1.81
A maize cDNA encoding a member of the retinoblastoma protein family: involvement in endoreduplication. Proc Natl Acad Sci U S A (1996) 1.81
The amino-terminal region of the retinoblastoma gene product binds a novel nuclear matrix protein that co-localizes to centers for RNA processing. J Cell Biol (1994) 1.80
Differential regulation of retinoblastoma tumor suppressor protein by G(1) cyclin-dependent kinase complexes in vivo. Mol Cell Biol (2001) 1.78
pVHL19 is a biologically active product of the von Hippel-Lindau gene arising from internal translation initiation. Proc Natl Acad Sci U S A (1998) 1.74
The transcription factor E2F-1 mediates the autoregulation of RB gene expression. Mol Cell Biol (1994) 1.73
The promyelocytic leukemia gene product (PML) forms stable complexes with the retinoblastoma protein. Mol Cell Biol (1998) 1.69
Hypo-phosphorylation of the retinoblastoma protein (pRb) by cyclin D:Cdk4/6 complexes results in active pRb. Proc Natl Acad Sci U S A (1997) 1.67
Distinct sub-populations of the retinoblastoma protein show a distinct pattern of phosphorylation. EMBO J (1994) 1.67
The human retinoblastoma gene is imprinted. PLoS Genet (2009) 1.63
Differential roles of two tandem E2F sites in repression of the human p107 promoter by retinoblastoma and p107 proteins. Mol Cell Biol (1995) 1.61
Functional interactions between the retinoblastoma (Rb) protein and Sp-family members: superactivation by Rb requires amino acids necessary for growth suppression. Proc Natl Acad Sci U S A (1995) 1.61
Expression and state of phosphorylation of the retinoblastoma susceptibility gene product in cycling and noncycling human hematopoietic cells. Proc Natl Acad Sci U S A (1990) 1.57
The N-Myc oncoprotein is associated in vivo with the phosphoprotein Max(p20/22) in human neuroblastoma cells. EMBO J (1991) 1.52
Cyclin D1 and human neoplasia. Mol Pathol (1998) 1.50
Structure of the human retinoblastoma gene. Proc Natl Acad Sci U S A (1989) 1.44
E1A induces phosphorylation of the retinoblastoma protein independently of direct physical association between the E1A and retinoblastoma products. Mol Cell Biol (1991) 1.41
A new member of the hsp90 family of molecular chaperones interacts with the retinoblastoma protein during mitosis and after heat shock. Mol Cell Biol (1996) 1.40
Localization of the MEN1 gene to a small region within chromosome 11q13 by deletion mapping in tumors. Proc Natl Acad Sci U S A (1990) 1.36
Retinoblastoma susceptibility genes contain 5' sequences with a high propensity to form guanine-tetrad structures. Nucleic Acids Res (1992) 1.35
DNA-binding properties of the E1A-associated 300-kilodalton protein. Mol Cell Biol (1992) 1.31
The retinoblastoma gene functions as a growth and tumor suppressor in human bladder carcinoma cells. Proc Natl Acad Sci U S A (1991) 1.29
Expression of the retinoblastoma protein is regulated in normal human tissues. Am J Pathol (1994) 1.28
Molecular mechanism of retinoblastoma gene inactivation in retinoblastoma cell line Y79. Proc Natl Acad Sci U S A (1988) 1.27
A bipartite nuclear localization signal in the retinoblastoma gene product and its importance for biological activity. Mol Cell Biol (1993) 1.27
The human oncoprotein MDM2 arrests the cell cycle: elimination of its cell-cycle-inhibitory function induces tumorigenesis. EMBO J (1998) 1.26
Cyclin D activates the Rb tumor suppressor by mono-phosphorylation. Elife (2014) 1.26
Infrequent genomic rearrangement and normal expression of the putative RB1 gene in retinoblastoma tumors. Mol Cell Biol (1988) 1.22
The Ah receptor and the mechanism of dioxin toxicity. Biochem J (1991) 1.22
The ninth Gordon Hamilton-Fairley memorial lecture. Hereditary cancers: clues to mechanisms of carcinogenesis. Br J Cancer (1989) 1.22
Factor-binding element in the human c-myc promoter involved in transcriptional regulation by transforming growth factor beta 1 and by the retinoblastoma gene product. Proc Natl Acad Sci U S A (1991) 1.18
Nuclear binding of purified retinoblastoma gene product is determined by cell cycle-regulated phosphorylation. Mol Cell Biol (1992) 1.18
Nuclear protein phosphorylation and growth control. Biochem J (1992) 1.16
Hyperphosphorylation of the retinoblastoma gene product is determined by domains outside the simian virus 40 large-T-antigen-binding regions. Mol Cell Biol (1990) 1.16
Purification and characterization of human papillomavirus type 16 E7 protein with preferential binding capacity to the underphosphorylated form of retinoblastoma gene product. J Virol (1991) 1.14
Asbestos fibers mediate transformation of monkey cells by exogenous plasmid DNA. Proc Natl Acad Sci U S A (1988) 1.14
Our changing view of the genomic landscape of cancer. J Pathol (2010) 1.13
p53, Rb and bcl-2 expression during the cell cycle: a study in phytohaemagglutinin stimulated lymphocytes and microwave irradiated lymphoid tissue sections. J Clin Pathol (1995) 1.13
Induction of transforming growth factor beta 1 resistance by the E1A oncogene requires binding to a specific set of cellular proteins. Proc Natl Acad Sci U S A (1991) 1.12
Loss of heterozygosity suggests multiple genetic alterations in pheochromocytomas and medullary thyroid carcinomas. J Clin Invest (1991) 1.11
Expression of p27(kip) and other cell cycle regulators in malignant peripheral nerve sheath tumors and neurofibromas: the emerging role of p27(kip) in malignant transformation of neurofibromas. Am J Pathol (1999) 1.11
Control of junB and extracellular matrix protein expression by transforming growth factor-beta 1 is independent of simian virus 40 T antigen-sensitive growth-sensitive growth-inhibitory events. Mol Cell Biol (1991) 1.10
Role of the retinoblastoma gene in the initiation and progression of human cancer. J Clin Invest (1990) 1.10
Enhanced tumor cell growth suppression by an N-terminal truncated retinoblastoma protein. Proc Natl Acad Sci U S A (1994) 1.08
The genetics of retinoblastoma. Br J Cancer (1991) 1.07
Deletion of Rb accelerates pancreatic carcinogenesis by oncogenic Kras and impairs senescence in premalignant lesions. Gastroenterology (2011) 1.05
Induction of sensitivity to the cytotoxic action of tumor necrosis factor alpha by adenovirus E1A is independent of transformation and transcriptional activation. J Virol (1990) 1.04
Human papillomavirus type 16 E7 protein inhibits DNA binding by the retinoblastoma gene product. Mol Cell Biol (1992) 1.03
Molecular detection of chromosomal translocations that disrupt the putative retinoblastoma susceptibility locus. Mol Cell Biol (1989) 1.00
Correlation between retinoblastoma gene expression and differentiation in human testicular tumors. Proc Natl Acad Sci U S A (1991) 1.00
Human papillomavirus type 16 E7 oncoprotein binds and inactivates growth-inhibitory insulin-like growth factor binding protein 3. Mol Cell Biol (2000) 1.00
Simian virus 40 large T antigen induces or activates a protein kinase which phosphorylates the transformation-associated protein p53. J Virol (1990) 1.00
Human retinoblastoma gene: long-range mapping and analysis of its deletion in a breast cancer cell line. Mol Cell Biol (1989) 0.98
Putting the pieces together: How is the mitochondrial pathway of apoptosis regulated in cancer and chemotherapy? Cancer Metab (2014) 0.97
Recessive mechanisms of malignancy. Br J Cancer (1988) 0.95
Lack of expression of aminoacylase-1 in small cell lung cancer. Evidence for inactivation of genes encoded by chromosome 3p. J Clin Invest (1989) 0.95
p107 in the public eye: an Rb understudy and more. Cell Div (2010) 0.94
Retinoblastoma tumor suppressor: analyses of dynamic behavior in living cells reveal multiple modes of regulation. Mol Cell Biol (2003) 0.94
Retinoblastoma (RB1) gene product expression in breast carcinoma. Correlation with Ki-67 growth fraction and biopathological profile. J Clin Pathol (1998) 0.92
Overproduction of Rb protein after the G1/S boundary causes G2 arrest. Mol Cell Biol (1993) 0.91
Identification and characterization of a RING zinc finger gene (C-RZF) expressed in chicken embryo cells. Proc Natl Acad Sci U S A (1996) 0.91
Evidence that the familial adenomatous polyposis gene is involved in a subset of colon cancers with a complementable defect in c-myc regulation. Proc Natl Acad Sci U S A (1989) 0.90
CpG island methylation status and mutation analysis of the RB1 gene essential promoter region and protein-binding pocket domain in nervous system tumours. Br J Cancer (2003) 0.90
RNA polymerase III repression by the retinoblastoma tumor suppressor protein. Biochim Biophys Acta (2012) 0.89
Neuronal and glial properties of a murine transgenic retinoblastoma model. Am J Pathol (1991) 0.88
Cancer stem cells: biological functions and therapeutically targeting. Int J Mol Sci (2014) 0.87
Further characterization of retinoblastoma gene-mediated cell growth and tumor suppression in human cancer cells. Proc Natl Acad Sci U S A (1994) 0.86
Tumour immunogenicity, antigen presentation and immunological barriers in cancer immunotherapy. New J Sci (2014) 0.85
Optical coherence tomography enables imaging of tumor initiation in the TAg-RB mouse model of retinoblastoma. Mol Vis (2015) 0.85
Expression of class I and II major histocompatibility complex antigens in Wilms' tumour and normal developing human kidney. Br J Cancer (1988) 0.84
Changes in retinoblastoma gene expression during cervical cancer progression. Int J Exp Pathol (2002) 0.81
Maintenance of cellular proliferation by adenovirus early region 1A in fibroblasts conditionally immortalized by using simian virus 40 large T antigen requires conserved region 1. Mol Cell Biol (1990) 0.81
Molecular genetic aspects of human cancers: the 1993 Frank Rose Lecture. Br J Cancer (1993) 0.81
Trilateral retinoblastoma in transgenic mice. Trans Am Ophthalmol Soc (1989) 0.81
CRISPR/Cas9 and cancer targets: future possibilities and present challenges. Oncotarget (2016) 0.81
SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell (1988) 12.69
Human retinoblastoma susceptibility gene: cloning, identification, and sequence. Science (1987) 6.93
Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation. Cell (1989) 6.46
The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle. Cell (1991) 4.69
Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells. Science (1988) 4.54
Social amnesia in mice lacking the oxytocin gene. Nat Genet (2000) 4.52
The neurobiology of attachment. Nat Rev Neurosci (2001) 4.22
BRCA2 is required for ionizing radiation-induced assembly of Rad51 complex in vivo. Cancer Res (1999) 4.16
Inactivation of the retinoblastoma susceptibility gene in human breast cancers. Science (1988) 4.15
Functional link between ataxia-telangiectasia and Nijmegen breakage syndrome gene products. Nature (2000) 3.96
Escherichia coli hemolysin is released extracellularly without cleavage of a signal peptide. J Bacteriol (1985) 3.82
Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15,000 adults. Arch Intern Med (2001) 3.68
Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated RB gene. Science (1990) 3.58
Oxytocin in the medial amygdala is essential for social recognition in the mouse. J Neurosci (2001) 3.40
Nuclease activities in a complex of human recombination and DNA repair factors Rad50, Mre11, and p95. J Biol Chem (1998) 3.40
Interaction of mouse mammary epithelial cells with collagen substrata: regulation of casein gene expression and secretion. Proc Natl Acad Sci U S A (1985) 3.23
Modulation of secreted proteins of mouse mammary epithelial cells by the collagenous substrata. J Cell Biol (1984) 3.16
Transgenic Polyoma middle-T mice model premalignant mammary disease. Cancer Res (2001) 2.97
Genetic mechanisms of tumor suppression by the human p53 gene. Science (1990) 2.68
Experimental allergic uveitis. Isolation, characterization, and localization of a soluble uveitopathogenic antigen from bovine retina. J Immunol (1977) 2.48
Functional link of BRCA1 and ataxia telangiectasia gene product in DNA damage response. Nature (2000) 2.44
The Philippine cynomolgus monkey (Macaca fasicularis) provides a new nonhuman primate model of tuberculosis that resembles human disease. Nat Med (1996) 2.40
A prospective randomized trial of cannulation technique in ERCP: effects on technical success and post-ERCP pancreatitis. Endoscopy (2008) 2.40
Oxytocin is required for nursing but is not essential for parturition or reproductive behavior. Proc Natl Acad Sci U S A (1996) 2.31
Deficiency of retinoblastoma protein leads to inappropriate S-phase entry, activation of E2F-responsive genes, and apoptosis. Proc Natl Acad Sci U S A (1995) 2.27
Human retinoblastoma susceptibility gene: genomic organization and analysis of heterozygous intragenic deletion mutants. Proc Natl Acad Sci U S A (1988) 2.22
Heterozygous Rb-1 delta 20/+mice are predisposed to tumors of the pituitary gland with a nearly complete penetrance. Oncogene (1994) 2.20
Characterization of a new continuous cell line derived from a human retinoblastoma. Cancer Res (1977) 2.16
Hypoxia-altitude simulation test. Evaluation of patients with chronic airway obstruction. Am Rev Respir Dis (1984) 2.15
DNA damage-induced cell cycle checkpoints and DNA strand break repair in development and tumorigenesis. Oncogene (1999) 2.10
A retinoblastoma-binding protein related to a negative regulator of Ras in yeast. Nature (1993) 2.03
CD44v(3,8-10) is involved in cytoskeleton-mediated tumor cell migration and matrix metalloproteinase (MMP-9) association in metastatic breast cancer cells. J Cell Physiol (1998) 1.93
Acute abdominal pain in systemic lupus erythematosus: focus on lupus enteritis (gastrointestinal vasculitis). Ann Rheum Dis (2002) 1.83
Suppression of tumorigenicity of glioblastoma cells by adenovirus-mediated MMAC1/PTEN gene transfer. Cancer Res (1998) 1.83
Lower CSF oxytocin concentrations in women with a history of childhood abuse. Mol Psychiatry (2008) 1.82
Naturally occurring differences in maternal care are associated with the expression of oxytocin and vasopressin (V1a) receptors: gender differences. J Neuroendocrinol (2002) 1.81
Characterization of the oxytocin system regulating affiliative behavior in female prairie voles. Neuroscience (2009) 1.80
Distribution of corticosteroid receptors in the rhesus brain: relative absence of glucocorticoid receptors in the hippocampal formation. J Neurosci (2000) 1.78
Facilitation of affiliation and pair-bond formation by vasopressin receptor gene transfer into the ventral forebrain of a monogamous vole. J Neurosci (2001) 1.71
Transmission disequilibrium testing of arginine vasopressin receptor 1A (AVPR1A) polymorphisms in autism. Mol Psychiatry (2002) 1.70
Radiation-induced assembly of Rad51 and Rad52 recombination complex requires ATM and c-Abl. J Biol Chem (1999) 1.68
Vasopressin-dependent neural circuits underlying pair bond formation in the monogamous prairie vole. Neuroscience (2004) 1.67
Collagenous substrata regulate the nature and distribution of glycosaminoglycans produced by differentiated cultures of mouse mammary epithelial cells. Exp Cell Res (1985) 1.66
A cellular protein that competes with SV40 T antigen for binding to the retinoblastoma gene product. Nature (1991) 1.66
Autoradiographic and in situ hybridization localization of corticotropin-releasing factor 1 and 2 receptors in nonhuman primate brain. J Comp Neurol (1999) 1.63
A dominant Stargardt's macular dystrophy locus maps to chromosome 13q34. Arch Ophthalmol (1994) 1.59
Infant vocalization, adult aggression, and fear behavior of an oxytocin null mutant mouse. Horm Behav (2000) 1.59
Structure of the mouse mammary tumor virus: polypeptides and glycoproteins. J Virol (1974) 1.56
Vortex or whorl formation of cultured human corneal epithelial cells induced by magnetic fields. Eye (Lond) (1996) 1.54
The retinoblastoma protein: more than a tumor suppressor. Annu Rev Cell Biol (1994) 1.54
Species and individual differences in juvenile female alloparental care are associated with oxytocin receptor density in the striatum and the lateral septum. Horm Behav (2006) 1.53
Adenoviral transgene expression of MMAC/PTEN in human glioma cells inhibits Akt activation and induces anoikis. Cancer Res (1998) 1.52
Oxytocin receptors in the nucleus accumbens facilitate "spontaneous" maternal behavior in adult female prairie voles. Neuroscience (2006) 1.50
A novel gene for autosomal dominant Stargardt-like macular dystrophy with homology to the SUR4 protein family. Invest Ophthalmol Vis Sci (2001) 1.48
Species differences in paternal behavior and aggression in peromyscus and their associations with vasopressin immunoreactivity and receptors. Horm Behav (1999) 1.48
Oral tolerance in experimental autoimmune uveoretinitis. Distinct mechanisms of resistance are induced by low dose vs high dose feeding protocols. J Immunol (1993) 1.47
Mutational analysis of the catalytic subunit of muscle protein phosphatase-1. Biochemistry (1996) 1.46
Paclitaxel (Taxol): an inhibitor of angiogenesis in a highly vascularized transgenic breast cancer. Cancer Biother Radiopharm (1999) 1.46
Structure of the human retinoblastoma gene. Proc Natl Acad Sci U S A (1989) 1.44
Space-occupying orbital masses in children. A review of 250 consecutive biopsies. Ophthalmology (1986) 1.43
The influence of host and tissue age on life span and growth rate of serially transplanted mouse mammary gland. Exp Gerontol (1971) 1.41
Mice deficient in both p53 and Rb develop tumors primarily of endocrine origin. Cancer Res (1995) 1.40
A protein phosphatase-1-binding motif identified by the panning of a random peptide display library. J Biol Chem (1997) 1.40
ATM-dependent phosphorylation of human Rad9 is required for ionizing radiation-induced checkpoint activation. J Biol Chem (2001) 1.38
Retinal ischemia and risk of neovascularization following central retinal vein obstruction. Ophthalmology (1982) 1.38
Dual retinoblastoma-binding proteins with properties related to a negative regulator of ras in yeast. J Biol Chem (1995) 1.37
Identification of a major pathogenic epitope in the human IRBP molecule recognized by mice of the H-2r haplotype. Invest Ophthalmol Vis Sci (1995) 1.37
Comparative genomic hybridization, allelic imbalance, and fluorescence in situ hybridization on chromosome 8 in prostate cancer. Genes Chromosomes Cancer (1994) 1.37
Helicobacter pylori infection is not associated with diabetes mellitus, nor with upper gastrointestinal symptoms in diabetes mellitus. Am J Gastroenterol (2001) 1.37
Coupled transcriptional and translational control of cyclin-dependent kinase inhibitor p18INK4c expression during myogenesis. Mol Cell Biol (1998) 1.36
The substrate specificity of amylopectin-debranching enzymes from sweet corn. Arch Biochem Biophys (1971) 1.36
The tumor suppressor PTEN negatively regulates insulin signaling in 3T3-L1 adipocytes. J Biol Chem (2000) 1.35
Ovarian steroid cell tumors, not otherwise specified: a case report and literature review. Gynecol Oncol (1999) 1.35
Purification and properties of rabbit liver phosphorylase phosphatase. J Biol Chem (1975) 1.34
Dentate granule cells form novel basal dendrites in a rat model of temporal lobe epilepsy. Neuroscience (1998) 1.30
Mutations in the 2-microns circle site-specific recombinase that abolish recombination without affecting substrate recognition. Proc Natl Acad Sci U S A (1987) 1.30
Management of posterior uveal melanoma. Surv Ophthalmol (1992) 1.29
Structure and methylation-associated silencing of a gene within a homozygously deleted region of human chromosome band 8p22. Genomics (1996) 1.29
Physical mapping of chromosome 8p22 markers and their homozygous deletion in a metastatic prostate cancer. Genomics (1996) 1.27
Molecular mechanism of retinoblastoma gene inactivation in retinoblastoma cell line Y79. Proc Natl Acad Sci U S A (1988) 1.27
Polypeptide variants of beta-arrestin and arrestin3. J Biol Chem (1993) 1.27
Enzymic methods for the microdetermination of glycogen and amylopectin, and their unit-chain lengths. Arch Biochem Biophys (1966) 1.27
The influence of mammogenic hormones on serially transplanted mouse mammary gland. Exp Gerontol (1971) 1.26
Deletion of a splice donor site ablates expression of the following exon and produces an unphosphorylated RB protein unable to bind SV40 T antigen. Cell Growth Differ (1990) 1.25
Primary and secondary structure of bovine retinal S antigen (48-kDa protein). Proc Natl Acad Sci U S A (1987) 1.25
Expression of the catalytic subunit of phosphorylase phosphatase (protein phosphatase-1) in Escherichia coli. J Biol Chem (1992) 1.24
Localization and dynamic relocalization of mammalian Rad52 during the cell cycle and in response to DNA damage. Curr Biol (1999) 1.23
Foetus in foetu. Arch Dis Child (1965) 1.22